ClinicalTrials.Veeva

Menu

Tracheal Positive Pressure During High Flow Nasal Oxygen Administration in Critically Ill Patients: a Physiologic Study. (HPEEP)

A

Azienda Sanitaria-Universitaria Integrata di Udine

Status

Not yet enrolling

Conditions

Positive End Expiratory Pressure
Airway Disease
Critically Ill
Diaphragm Disease
High Flow Nasal Cannula
Acute Respiratory Failure

Treatments

Device: HIGH FLOW NASAL OXYGEN

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

High flow nasal cannula administration in critically ill patients is frequently used to improve acute respiratory failure or to prevent respiratory failure after extubation.

It acts generating a mild positive pressure in the airways and by reducing respiratory effort of patients.

However to the best of our knowledge, no study to date has directly measured the amount of positive pressure generated in the trachea of patients.

The primary aim, therefore, of this study measures this positive pressure after extubation in critically ill patients.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: CRITICALLY ILL PATIENTS AFTER MECHANICAL VENTILATION LASTED AT LEAST 72 HOURS

  • age 18-80 years

Exclusion Criteria:

  • COPD stage >1 according to GOLD classification
  • end stage organ disease (liver, kidney, heart, lung)
  • neuromuscular disease
  • neoplasm
  • previous tracheostomy
  • obesity with BMI > 35 Kg/m2
  • non collaborative patient

Trial design

20 participants in 1 patient group

CRITICALLY ILL PATIENTS
Description:
CRITICALLY ILL PATIENTS AFTER INVASIVE MECHANICAL VENTILATION READY TO BE EXTUBATED.
Treatment:
Device: HIGH FLOW NASAL OXYGEN

Trial contacts and locations

1

Loading...

Central trial contact

Cristian Deana, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems